Misoprostol for Treatment of Incomplete Abortion: Tr aining Guide 22. Parashar P, Iversen OE, Midbøe G, et al. Medical abortion in the first trimester: the use of serum hCG and the endometrial thickness as markers of completeness. Eur J Contracept Reprod Health Care 2007; 12(4): 366-371. 23. Reeves MF, Fox MC, Lohr PA, et al. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol 2009; 34(1): 104-109. 24. Rørbye C, Nørgaard M, Nilas L. Prediction of late failure after medical abortioin from serial β-hCG measurements and ultrasonography. Hum Reprod 2004; 19(1): 85-89. 25. Shwekerela B, Kalumuna R, Kipingili R, et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: Results from Tanzania. BJOG 2007; 114(11): 1363-1367. 26. Taylor J, Diop A, Blum J, et al. Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana. Int J Gynecol Obstet 2010; 112(1): 40-44. 27. Weeks A, Alia G, Blum J, et al. A randomized trial of oral misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in Kampala, Uganda. Obstet Gynecol 2005; 106(3): 540-547. 28. World Health Organization. Safe Abortion: technical and policy guidance for health systems, Second Edition. Geneva, Switerland: World Health Organization, 2012. 29. World Health Organization. WHO Model List of Essential Medicines, 17th List. Geneva, Switzerland: World Health Organization, March 2011.
174 References